Education
About Us
Working with TipRanks
Follow Us
Quantum-Si (QSI)
NASDAQ:QSI
QSI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.61 - $5.77
Previous CloseN/A
Volume35.47M
Average Volume (3M)7.17M
Market Cap
$208.57M
Enterprise Value$156.84M
Total Cash (Recent Filing)$214.21M
Total Debt (Recent Filing)$11.14M
Price to Earnings (P/E)―
Beta2.64
Next Earnings
Nov 05, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding182,557,700
10 Day Avg. Volume7,689,821
30 Day Avg. Volume7,169,671
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.75
Enterprise Value/Revenue45.97
Enterprise Value/Gross Profit86.46
Enterprise Value/Ebitda-1.47
Forecast
1Y Price Target
$4.00Price Target Upside260.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
PartnershipsThe company's partnership with Avantor is viewed as a tailwind to sales in the biopharma sector.
Product DevelopmentFocus remains on the long term with the anticipated launch of their next-generation protein sequencing device, Proteus.
Sales StrategyQuantum-SI expanded the breadth and flexibility of purchasing options for their legacy machine, Platinum, which could help potential consumers get accustomed to the new protein sequencing technology.
Bears Say
Financial PerformanceManagement reported markedly lower revenue than the consensus expectation, attributing it partially to NIH funding challenges and a shift towards biopharmaceutical companies with longer sales cycles.
Market PenetrationIt may take significant time before QSI can penetrate the protein sequencing opportunity.
RevenueThe company reported total revenues of $808K, lower than consensus estimated revenue of $960K for 1Q25.
Quantum-Si News
QSI FAQ
What was Quantum-Si’s price range in the past 12 months?
Quantum-Si lowest stock price was $0.61 and its highest was $5.77 in the past 12 months.
What is Quantum-Si’s market cap?
Quantum-Si’s market cap is $208.57M.
When is Quantum-Si’s upcoming earnings report date?
Quantum-Si’s upcoming earnings report date is Nov 05, 2025 which is in 74 days.
How were Quantum-Si’s earnings last quarter?
Quantum-Si released its earnings results on Aug 05, 2025. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.143 by -$0.017.
Is Quantum-Si overvalued?
According to Wall Street analysts Quantum-Si’s price is currently Undervalued.
Does Quantum-Si pay dividends?
Quantum-Si does not currently pay dividends.
What is Quantum-Si’s EPS estimate?
Quantum-Si’s EPS estimate is -0.13.
How many shares outstanding does Quantum-Si have?
Quantum-Si has 182,557,700 shares outstanding.
What happened to Quantum-Si’s price movement after its last earnings report?
Quantum-Si reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.143. Following the earnings report the stock price went down -4.861%.
Which hedge fund is a major shareholder of Quantum-Si?
Currently, no hedge funds are holding shares in QSI
Quantum-Si Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (260.36% Upside)
$4.00 (260.36% Upside)
Blogger Sentiment
Neutral
QSI Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 752.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $106.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 4.2%
Last 30 Days ▼ 4.2%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
9.90%
12-Months-Change
Fundamentals
Return on Equity
-46.87%
Trailing 12-Months
Asset Growth
-0.91%
Trailing 12-Months
Company Description
Quantum-Si
Quantum-Si (QSI) is a biotechnology company focused on revolutionizing the field of proteomics through the development of next-generation protein sequencing technology. The company's core product is the Platinum™ platform, which aims to simplify and accelerate the analysis of proteins. By providing a more comprehensive understanding of proteins, Quantum-Si seeks to advance the discovery and development of new biomarkers and therapeutics, ultimately enhancing personalized medicine approaches.
QSI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While there were significant advancements in product development and strategic initiatives to counteract capital sales challenges, revenue fell short of expectations due to NIH funding uncertainties. The company's strong cash position and innovation roadmap progress are positives, but the lack of financial guidance and increased operating expenses indicate ongoing challenges.View all QSI earnings summariesQSI Stock 12 Month Forecast
Average Price Target
$4.00
▲(260.36% Upside)
Technical Analysis
Nautilus Biotechnolgy
―
Foghorn Therapeutics
―
Atea Pharmaceuticals
―
Compass Therapeutics
―
Seer
―
Ownership Overview
23.17% Insiders
5.66% Mutual Funds
11.87% Other Institutional Investors
47.06% Public Companies and
Individual Investors